Hepatic Fibrosis: Pathogenesis, Diagnosis and Emerging Therapies, An Issue of Clinics in Liver Disease, 1st Edition
Author :
By Scott Friedman
Hepatic fibrosis is the final common pathway for a multitude of liver injuries. Viral-, immune-, or toxin-mediated liver injuries all result in expansion of the extracellular matrix with distortion of hepatic architecture and development of cirrhosis
...view more
Hepatic fibrosis is the final common pathway for a multitude of liver injuries. Viral-, immune-, or toxin-mediated liver injuries all result in expansion of the extracellular matrix with distortion of hepatic architecture and development of cirrhosis. Originally thought of as a one-way street, hepatic fibrosis now is recognized as a dynamic process with the potential for significant resolution. Authors in this issue address the genetic determinants of fibrosis, oxidant stress, cellular contractility and vasoregulation, as well as relationships between stellate cell activation, progenitor cells and hepatic regeneration. Current and future antifibrotic therapies are also discussed.
Hepatic fibrosis is the final common pathway for a multitude of liver injuries. Viral-, immune-, or toxin-mediated liver injuries all result in expansion of the extracellular matrix with distortion of hepatic architecture and development of cirrhosis. Originally thought of as a one-way street, hepatic fibrosis now is recognized as a dynamic process with the potential for significant resolution. Authors in this issue address the genetic determinants of fibrosis, oxidant stress, cellular contractility and vasoregulation, as well as relationships between stellate cell activation, progenitor cells and hepatic regeneration. Current and future antifibrotic therapies are also discussed.
https://www.elsevierhealth.com.au/hepatic-fibrosis-pathogenesis-diagnosis-and-emerging-therapies-an-issue-of-clinics-in-liver-disease-9781416063155.html299404Hepatic Fibrosis: Pathogenesis, Diagnosis and Emerging Therapies, An Issue of Clinics in Liver Diseasehttps://www.elsevierhealth.com.au/media/catalog/product/https://www.elsevierhealth.com.au/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.png81.75109AUDInStock/Medicine & Surgery/Nephrology/Medicine & Surgery/Gastroenterology & Hepatology/Clinics/Clinics/Japan Titles433515443351394388725525504152631601418269243350885145120Hepatic fibrosis is the final common pathway for a multitude of liver injuries. Viral-, immune-, or toxin-mediated liver injuries all result in expansion of the extracellular matrix with distortion of hepatic architecture and development of cirrhosis. Originally thought of as a one-way street, hepatic fibrosis now is recognized as a dynamic process with the potential for significant resolution. Authors in this issue address the genetic determinants of fibrosis, oxidant stress, cellular contractility and vasoregulation, as well as relationships between stellate cell activation, progenitor cells and hepatic regeneration. Current and future antifibrotic therapies are also discussed. Hepatic fibrosis is the final common pathway for a multitude of liver injuries. Viral-, immune-, or toxin-mediated liver injuries all result in expansion of the extracellular matrix with distortion of hepatic architecture and development of cirrhosis. Originally thought of as a one-way street, hepatic fibrosis now is recognized as a dynamic process with the potential for significant resolution. Authors in this issue address the genetic determinants of fibrosis, oxidant stress, cellular contractility and vasoregulation, as well as relationships between stellate cell activation, progenitor cells and hepatic regeneration. Current and future antifibrotic therapies are also discussed.00add-to-cart97814160631552011 and earlierProfessionalBy Scott Friedman20081BookOtherSaunders2401 Dec 2008Please allow 3-4 weeks for deliveryBy <STRONG>Scott Friedman</STRONG>ClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select